Archive for October 6, 2016

Breakthrough Therapy for Patients with Giant Cell Arteritis

FDA Grants Breakthrough Therapy Designation for GENENTECH’S Actemra® (tocilizumab) in Giant Cell Arteritis, A form of vasculitis Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced more »


Read More

Support the VF through the Amazon Smile Program

Just in time for your holiday shopping! AmazonSmile is a simple and automatic way for you to support the Vasculitis Foundation every time you shop, at no cost to you. more »


Read More